Revitope Oncology Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include Exelixis and Heidelberg Pharma.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Heidelberg Pharma Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. | ||
Founding Date | Founding Date 2003 | Founding Date 1994 | Founding Date 1997 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Rockville, US HQ | Locations Alameda, US HQ | Locations Ladenburg, DE HQ Ladenburg, DE |
Employees | Employees 5025% increase | Employees 1,14712% decrease | Employees 60 |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 8.2 b | Valuation ($) 158.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) €1.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) | Cost of goods (€2.5m) (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $2.2b (FY, 2025) | Gross profit €6.3m (FY, 2025) |
Net income | Net income ($153.9m) (FY, 2025) | Net income $782.6m (FY, 2025) | Net income (€42.3m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyHeidelberg Pharma
HQ
Ladenburg, DE
Employees
60
Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.
View company